Skip to main content
logo
Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia flag Australia · Delayed Price · Currency is AUD
0.2600
0.00 (0.00%)
Mar 31, 2026, 4:10 PM AEST

ASX:PAR Revenue

Paradigm Biopharmaceuticals had revenue of 25.15K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 8.45K, down -49.40% year-over-year.

Revenue (ttm)
8.45K
Revenue Growth
-49.40%
P/S Ratio
13,689.48
Revenue / Employee
n/a
Employees
n/a
Market Cap
115.68M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025---
Jun 30, 2024---
Jun 30, 2023---
Jun 30, 202279.22K58.67K285.52%
Jun 30, 202120.55K--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Botanix Pharmaceuticals21.92M
Radiopharm Theranostics16.28M
Dimerix7.42M
Actinogen Medical7.36M
Alterity Therapeutics6.64M
Amplia Therapeutics5.01M
Arovella Therapeutics3.21M
Cynata Therapeutics1.69M
Revenue Rankings

Paradigm Biopharmaceuticals News

More News